A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

Clinical trial NCT02890069 · COMPLETED

Trial details

NCT number: NCT02890069
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma

Start date: 2016-10-14
Primary completion: 2022-02-22
Enrollment: 298

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.